Iodine Deficiency: Causes, Symptoms, and Treatment

What Is Iodine and Why Does the Thyroid Need It?

The thyroid gland incorporates iodine into every molecule of thyroid hormone it produces: two atoms for T3 (triiodothyronine) and four atoms for T4 (thyroxine). Without iodine, hormone synthesis halts. The pituitary responds by secreting more TSH, which forces the thyroid to enlarge in an attempt to capture every available iodine atom from the bloodstream. That enlargement is a goiter.

Dietary iodine is absorbed almost completely from the small intestine. The kidneys excrete roughly 90% of absorbed iodine in urine, which is why urinary iodine concentration (UIC) is the standard epidemiological marker of population status. Urinary iodine measurement methodology is described by the WHO/UNICEF/ICCIDD. A UIC <100 mcg/L in a population sample indicates deficiency; a UIC <20 mcg/L indicates severe deficiency [1].

The thyroid stores enough iodine to maintain hormone output for roughly two to three months, which is why frank deficiency takes time to produce measurable hypothyroidism in a previously replete adult. In a fetus, that buffer does not exist. Maternal iodine crosses the placenta and is the sole source of fetal thyroid hormone before the fetal gland matures at approximately 18 to 20 weeks of gestation [2].

T4 is the dominant secretory product; peripheral tissues convert T4 to the more metabolically active T3 via deiodinase enzymes. Selenium is required for that conversion step, which is why selenium deficiency can amplify the harm of borderline iodine insufficiency [3].

How Common Is Iodine Deficiency?

Iodine deficiency remains a global public-health problem despite decades of salt-iodization programs. The WHO estimates that approximately 2 billion people have insufficient iodine intake, and roughly 266 million school-age children remain iodine-deficient [1].

In the United States the picture is more nuanced. National Health and Nutrition Examination Survey (NHANES) data from 2011 to 2014 showed a median UIC of 144 mcg/L in the general adult population, a figure that sits in the adequate range but has declined substantially from the 320 mcg/L median recorded in the early 1970s [4]. Pregnant women fare worse: a separate NHANES analysis found a median UIC of 129 mcg/L in U.S. pregnant women, below the WHO adequacy threshold of 150 mcg/L for that group [4].

Several subgroups carry disproportionate risk. Pregnant and lactating women have elevated requirements (220 mcg/day and 290 mcg/day, respectively) [5]. People who avoid iodized salt, dairy, and seafood, including many vegans and those following elimination diets, can fall short of the 150 mcg/day adult requirement [6]. Individuals with inflammatory bowel disease or celiac disease may absorb less iodine from food [7].

Goitrogens compound the problem. These are naturally occurring compounds in cruciferous vegetables, cassava, and millet that compete with iodine uptake. They pose a meaningful risk only when iodine intake is already marginal [8].

Symptoms and Signs of Iodine Deficiency

Symptoms appear on a spectrum that tracks how severely and for how long iodine intake has been inadequate. Mild-to-moderate deficiency may produce no symptoms at all and be detected only through population screening.

When deficiency progresses to overt hypothyroidism, the clinical picture includes fatigue, weight gain, cold intolerance, constipation, dry skin, bradycardia, and cognitive slowing. These mirror the symptoms of hypothyroidism from any cause because the final common pathway is low thyroid hormone output [9]. A systematic review published in JAMA (2004) noted that TSH elevation is the earliest and most sensitive biochemical marker, appearing before free T4 falls [10].

Goiter is the cardinal physical sign. The WHO classifies goiter by palpation: Grade 0 means no palpable or visible goiter; Grade 1 means a palpable goiter not visible with the neck in normal position; Grade 2 means a goiter visible with the neck in normal position [1]. In regions where iodine deficiency is endemic, goiter prevalence can exceed 30% of the population [11].

Neurological consequences are the most devastating. Severe maternal deficiency during the first trimester causes cretinism, a syndrome of irreversible intellectual disability, deafness, and motor dysfunction. Milder in-utero deficiency reduces offspring IQ by an average of 13.5 IQ points, according to a meta-analysis of 18 studies [12]. That figure underlines why adequate iodine in pregnancy is not optional.

Diagnosing Iodine Deficiency

For individual patients, serum TSH is the primary screening test. An elevated TSH with a low free T4 confirms overt hypothyroidism. A mildly elevated TSH (typically 4.5 to 10 mIU/L) with a normal free T4 meets the diagnostic criteria for subclinical hypothyroidism, which may be the first biochemical signal of iodine-related thyroid stress [13].

UIC is used at the population level, not to diagnose individual deficiency, because single-void urine samples are highly variable. For individual assessment, a 24-hour urine iodine collection or a spot UIC combined with creatinine ratio offers better precision [14].

Thyroid ultrasound can quantify goiter volume and detect nodular changes. In areas of long-standing deficiency, thyroid nodularity is common and can raise concern for autonomous nodules that may cause hyperthyroidism if iodine is suddenly reintroduced in large amounts [15].

Thyroid peroxidase antibodies (TPOAb) and thyroglobulin antibodies (TgAb) help distinguish iodine-deficiency hypothyroidism from autoimmune thyroiditis (Hashimoto's disease). Positive antibody titers strongly favor autoimmune etiology [16].

Iodine Deficiency and Hypothyroidism

Chronic iodine deficiency is the single most preventable cause of hypothyroidism worldwide. When deficiency is severe, TSH rises high enough to stimulate thyroid growth and maximize iodine trapping, but hormone output still falls short [9]. The result is overt hypothyroidism requiring thyroid hormone replacement.

In iodine-sufficient countries like the United States, Hashimoto's thyroiditis overtakes deficiency as the leading cause of hypothyroidism. The American Thyroid Association guidelines (2014) recommend levothyroxine as first-line treatment for overt hypothyroidism regardless of underlying cause, targeting a TSH between 0.5 and 2.5 mIU/L in most adults [17]. Standard levothyroxine dosing starts at 1.6 mcg/kg/day, adjusted every six to eight weeks based on repeat TSH [17].

Correcting iodine deficiency in a patient who has not yet developed fixed hypothyroidism can normalize TSH without medication. However, once the thyroid has been damaged by years of TSH-driven hypertrophy or autoimmune attack, levothyroxine (brand names include Synthroid, Tirosint, and Levoxyl) is typically required long-term [9].

Subclinical Hypothyroidism: The Gray Zone

Subclinical hypothyroidism (SCH) is defined as a TSH above the upper reference limit (generally 4.5 mIU/L) with a normal free T4. It affects approximately 3 to 8% of the general population and up to 15 to 18% of women over age 60 [13].

Iodine insufficiency can drive TSH into the subclinical range before hormone levels drop. A prospective cohort study published in the Journal of Clinical Endocrinology and Metabolism (N=3,047) found that lower urinary iodine was independently associated with higher TSH after adjusting for age, sex, and BMI [18]. Whether to treat SCH pharmacologically is debated. The TRUST randomized trial (N=737, mean age 74) found that levothyroxine treatment of SCH in older adults produced no improvement in hypothyroid symptoms or quality of life compared with placebo [19]. Current American Thyroid Association guidance recommends treatment when TSH exceeds 10 mIU/L or when the patient is pregnant, trying to conceive, or symptomatic with a TSH between 4.5 and 10 mIU/L [17].

Untreated SCH carries modest cardiovascular risk. A meta-analysis in Annals of Internal Medicine (N=55,287) found that SCH with TSH 7.0 to 9.9 mIU/L was associated with a hazard ratio of 1.89 for coronary heart disease events [20].

Iodine, Hashimoto's Thyroiditis, and Autoimmunity

Hashimoto's thyroiditis is an autoimmune condition in which CD8+ cytotoxic T cells and antibodies against thyroid peroxidase and thyroglobulin progressively destroy thyroid parenchyma [16]. It is the most common autoimmune disease in the United States, affecting an estimated 14 million Americans, with a female-to-male ratio of roughly 7:1 [21].

The relationship between iodine and Hashimoto's is bidirectional and complex. Severe iodine deficiency depresses thyroid hormone production regardless of immune status. Conversely, high iodine intake may trigger or worsen autoimmune thyroiditis in genetically susceptible individuals. Animal and epidemiological data show that populations exposed to rapid iodine repletion after prolonged deficiency see transient spikes in TPOAb prevalence [22]. A study of the Chinese National Iodine Deficiency Disorders Survey (N=3,761) found that communities shifted from deficient to more-than-adequate iodine status had significantly higher rates of subclinical hypothyroidism and thyroid autoimmunity at five-year follow-up [23].

The clinical takeaway: iodine supplementation should be titrated to the recommended dietary allowance and not exceeded. Pharmacological iodine doses (milligram range) used without medical supervision may worsen autoimmune thyroid disease [22].

Iodine Deficiency and Graves' Disease

Graves' disease is the leading cause of hyperthyroidism in iodine-sufficient countries, driven by thyroid-stimulating immunoglobulins (TSI) that bind and activate the TSH receptor [24]. It is not caused by iodine deficiency. In fact, iodine-deficient populations tend to have lower rates of Graves' disease and higher rates of toxic multinodular goiter, a hyperthyroid condition that develops when autonomous nodules form in an iodine-deprived, TSH-stimulated gland over many years [15].

Reintroducing iodine to an iodine-deficient region can paradoxically precipitate hyperthyroidism in older patients who have autonomous nodules. This phenomenon, sometimes called the Jod-Basedow effect, was well-documented in Europe and Africa following iodized-salt programs [25]. Amiodarone, an antiarrhythmic drug that is 37% iodine by weight, can precipitate Jod-Basedow hyperthyroidism even in previously euthyroid patients with underlying nodular goiter [25].

If Graves' disease is diagnosed, treatment options include anti-thyroid medications (methimazole, starting dose typically 10 to 30 mg/day; or propylthiouracil for the first trimester of pregnancy), radioactive iodine ablation (RAI, typically I-131 at 10 to 15 mCi), or thyroidectomy [24]. The American Thyroid Association 2016 guidelines state: "We suggest that MMI be used in essentially every patient who chooses antithyroid drug therapy for GD" [24].

Iodine supplementation has no role in managing Graves' disease. Saturated solution of potassium iodide (SSKI) is used for a different and narrow indication: to reduce thyroid vascularity in the 10 days immediately before a thyroidectomy [24].

Iodine Requirements Across the Life Cycle

Requirements differ substantially by age and reproductive status. The National Academy of Medicine Dietary Reference Intakes establish the following [5]:

• Children ages 1 to 8: 90 mcg/day
• Children ages 9 to 13: 120 mcg/day
• Adults 14 and older: 150 mcg/day
• Pregnant women: 220 mcg/day
• Lactating women: 290 mcg/day

The tolerable upper intake level (UL) for adults is 1 to 100 mcg/day. Chronic intakes above that threshold increase the risk of thyroid dysfunction, including both hypothyroidism and hyperthyroidism [5].

The American Thyroid Association and the American College of Obstetricians and Gynecologists both recommend that pregnant and lactating women take a prenatal supplement containing 150 mcg of potassium iodide daily to ensure adequate intake even if diet is variable [26]. ACOG states in its 2015 Committee Opinion 753: "Women who are planning a pregnancy, pregnant, or breastfeeding should supplement their diet with a daily supplement containing 150 mcg of iodine" [26].

Dietary Sources of Iodine

Food-based iodine is concentrated in a small number of categories. Seaweed is the densest source, but iodine content varies by species and geography by more than 100-fold, making it unreliable as a primary source [6]. A single teaspoon of iodized salt provides approximately 300 mcg of iodine. One cup of low-fat cow's milk provides 85 to 90 mcg, and one large egg provides approximately 25 mcg [6].

Sea salt, Himalayan salt, and most artisan salts are not iodized. The shift toward specialty salts in health-conscious households is one plausible contributor to the decline in U.S. median UIC over the past five decades [4]. Fish and shellfish are reliable sources; a 3-ounce serving of cod provides roughly 99 mcg and an equivalent serving of shrimp about 35 mcg [6].

Plant-based diets require deliberate planning. A cross-sectional study (N=319) published in the British Journal of Nutrition found that vegans had a median UIC of 52 mcg/L compared to 147 mcg/L in omnivores, placing the vegan group in the deficient range [27].

Treatment: Correcting Iodine Deficiency

The treatment strategy depends on the severity of deficiency and whether thyroid dysfunction is already established. A practical decision framework follows.

Stage 1: Dietary insufficiency without thyroid dysfunction (TSH normal, UIC <100 mcg/L). Correct with iodized salt and dietary counseling. A multivitamin containing 150 mcg potassium iodide bridges dietary gaps. Recheck UIC at 6 months. No thyroid medication is needed.

Stage 2: Subclinical hypothyroidism (TSH 4.5 to 10 mIU/L, free T4 normal). Rule out autoimmune thyroiditis with TPOAb testing. If antibodies are negative and UIC is low, correct iodine deficiency and recheck TSH in 8 to 12 weeks. If TSH fails to normalize or antibodies are positive, follow American Thyroid Association subclinical hypothyroidism guidelines [17]. Consider levothyroxine if the patient is pregnant, trying to conceive, or symptomatic.

Stage 3: Overt hypothyroidism (TSH >10 mIU/L or elevated TSH plus low free T4). Start levothyroxine at 1.6 mcg/kg/day (or 25 to 50 mcg/day in older adults and those with cardiac disease) and titrate every 6 to 8 weeks to a target TSH of 0.5 to 2.5 mIU/L [17]. Correct iodine intake simultaneously, but do not expect iodine repletion alone to resolve overt hypothyroidism once the gland is damaged.

Stage 4: Goiter with nodularity (detected on ultrasound). Refer to endocrinology. Autonomous nodules discovered in the context of prior iodine deficiency require TSH suppression assessment and, if TSH is low, thyroid scintigraphy to rule out toxic nodular goiter [15].

Monitoring and Follow-Up

After initiating levothyroxine, TSH should be rechecked 6 to 8 weeks after each dose change [17]. Once stable, annual TSH monitoring is standard. Patients on levothyroxine who become pregnant need dose increases of approximately 30% as soon as pregnancy is confirmed and should be seen by an endocrinologist or high-risk obstetrician [28].

For patients managing iodine deficiency with dietary changes alone, a spot UIC or 24-hour urine collection at 6 months confirms repletion. A UIC between 100 and 299 mcg/L in adults and 150 to 249 mcg/L in pregnant women indicates adequate status [1].

Selenium co-supplementation at 55 to 200 mcg/day may reduce TPOAb titers in patients with Hashimoto's thyroiditis, according to a meta-analysis of 16 randomized controlled trials published in Thyroid (N=1,355) [29]. Selenium does not replace iodine, but the two nutrients work synergistically in thyroid hormone metabolism [3].